PATENT CLAIM ANALYSIS

Application Number: 15869431
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "006100"]

Abstract:
The present invention relates to methods that are useful for predicting the response of hepatitis B virus (HBV) infected patients to pharmacological treatment.

Claim (Index 8):
The method of  claim 7 , wherein the interferon is a peginterferon alfa-2a conjugate having the formula: wherein R and R\u2032 are methyl, X is NH, and n and n\u2032 are individually or both either 420 or 520.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.04
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14373611', '11375580', '10618620', '11375585', '13774960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5804244580790886
- 35 USC 102 Novelty (BERT): 0.5138205716202103
- Combined Prediction Score: 0.5737640694332008
- Mean Citation Score: 238.37690000000003
- Max Citation Score: 266.92334
- Similarity Product: 181.15325799752

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test